Related references
Note: Only part of the references are listed.Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model
Neelakshi R. Jog et al.
JOURNAL OF AUTOIMMUNITY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
Marc Desforges et al.
VIRUSES-BASEL (2020)
SARS-CoV-2 can induce brain and spine demyelinating lesions
Luca Zanin et al.
ACTA NEUROCHIRURGICA (2020)
Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease
Gianluca Isaia et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
Jerome R. Lechien et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2020)
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection
Marco Chiarini et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
COVID-19-associated acute disseminated encephalomyelitis (ADEM)
Timothy Parsons et al.
JOURNAL OF NEUROLOGY (2020)
Clinical Presentation of COVID19 in Dementia Patients
A. Bianchetti et al.
JOURNAL OF NUTRITION HEALTH & AGING (2020)
Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study
TieLong Chen et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia
Letterio S. Politi et al.
JAMA NEUROLOGY (2020)
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review
Adeel S. Zubair et al.
JAMA NEUROLOGY (2020)
Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder
Marina A. Creed et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration
Alice Lippi et al.
MOVEMENT DISORDERS (2020)
Effects ofCOVID-19 on Parkinson's Disease Clinical Features: ACommunity-Based Case-ControlStudy
Roberto Cilia et al.
MOVEMENT DISORDERS (2020)
Outcome of Parkinson's Disease Patients Affected by COVID-19
Angelo Antonini et al.
MOVEMENT DISORDERS (2020)
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Mahdi Barzegar et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Rapid worsening in Parkinson's disease may hide COVID-19 infection
Elodie Hainque et al.
PARKINSONISM & RELATED DISORDERS (2020)
Prognosis analysis of patients with mental disorders with COVID-19: a single -center retrospective study
Yan Wan et al.
AGING-US (2020)
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
Shelli Farhadian et al.
BMC NEUROLOGY (2020)
Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID-19): an experience in New York
Satoshi Miyashita et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2020)
Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years
Marcello Covino et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2020)
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Celine Louapre et al.
JAMA NEUROLOGY (2020)
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
Konrad Rejdak et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
Cristina Valencia-Sanchez et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
Kulachanya Suwanwongse et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
Giovanna Borriello et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
Farinaz Safavi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
Mahsa Ghajarzadeh et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Paloma Montero-Escribano et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Giovanni Novi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID
Celsi Fiorella et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Luis F. Garcia
FRONTIERS IN IMMUNOLOGY (2020)
The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis
Claire Boutoleau-Bretonniere et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
COVID-19 outcomes in MS Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center
Erica Parrotta et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology
Nikolaus Deigendesch et al.
ACTA NEUROPATHOLOGICA (2020)
Severe obesity, increasing age and male sex are independently associated with worse in -hospital outcomes, and higher in -hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
Leonidas Palaiodimos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy
Alfonso Fasano et al.
MOVEMENT DISORDERS (2020)
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
Hannah Wurm et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Case fatality of COVID-19 in patients with neurodegenerative dementia
J. A. Reyes-Bueno et al.
NEUROLOGIA (2020)
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
Jens Devogelaere et al.
NEUROLOGICAL SCIENCES (2020)
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
Gloria Dalla Costa et al.
NEUROLOGICAL SCIENCES (2020)
Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study
Jong-moon Hwang et al.
NEUROLOGICAL SCIENCES (2020)
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
Michael T. Heneka et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Lessons from a neurology consult service for patients with COVID-19
Lindsay S. McAlpine et al.
LANCET NEUROLOGY (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy
Paolo Giorgi Rossi et al.
PLOS ONE (2020)
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
Stephanie L. Harrison et al.
PLOS MEDICINE (2020)
A case of possible atypical demyelinating event of the central nervous system following COVID-19
Anahita Zoghi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
Francesco Crescenzo et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
Virginia Meca-Lallana et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
William L. Conte
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
Matteo Lucchini et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab
Jeanine Rempe Thornton et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
Clara Aguirre et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Multiple sclerosis following SARS-CoV-2 infection
M. Palao et al.
Multiple Sclerosis and Related Disorders (2020)
Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod
Giulia Mallucci et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab
Eva Fernandez-Diaz et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
Marco Iannetta et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
Marcello De Angelis et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside
David Sulzer et al.
NPJ PARKINSONS DISEASE (2020)
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020
Karima Benameur et al.
EMERGING INFECTIOUS DISEASES (2020)
Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action
Giulia Abate et al.
HEALTHCARE (2020)
Management of a Parkinson's disease patient with severe COVID-19 pneumonia
Jingwen Li et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The prevalence of MS in the United States A population-based estimate using health claims data
Mitchell T. Wallin et al.
NEUROLOGY (2019)
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >= 65 years
Kevin A. Matthews et al.
ALZHEIMERS & DEMENTIA (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus
Ben Readhead et al.
NEURON (2018)
Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model
Karine Bourgade et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review
Sven R. Suwijn et al.
EJNMMI RESEARCH (2015)
Predictors of hippocampal atrophy in critically ill patients
A. Lindlau et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Evidence of Inflammatory System Involvement in Parkinson's Disease
Yinxia Chao et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
Maria C. Leal et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Susan M. Landau et al.
NEUROBIOLOGY OF AGING (2011)
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
Theodore J. Iwashyna et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Neuroinflammation resulting from covert brain invasion by common viruses - A potential role in local and global neurodegeneration
Jeannine A. Majde
MEDICAL HYPOTHESES (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
Adam E. Handel et al.
PLOS ONE (2010)
Viral parkinsonism
Haeman Jang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Systemic inflammation and disease progression in Alzheimer disease
C. Holmes et al.
NEUROLOGY (2009)
Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
Haeman Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Parkinson's disease: a dual-hit hypothesis
C. H. Hawkes et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia
Y Li et al.
JOURNAL OF VIROLOGY (2004)
Neuroinvasion by human respiratory coronaviruses
N Arbour et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
